AB Corporate Bond ETF (NASDAQ:EYEG) Stock Short Interest Report for October

AB Corporate Bond ETF (NASDAQ:EYEG) was the target of a significant decrease in short interest in the month of October. As of October 30th, there was short interest totaling 43 shares, a decrease of 95.5% from the October 15th total of 950 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily volume of 5,020 shares, the short-interest ratio is currently 0.0 days.

AB Corporate Bond ETF Trading Down 0.6%

NASDAQ:EYEG traded down $0.21 during trading hours on Thursday, hitting $33.55. 37 shares of the company were exchanged, compared to its average volume of 538. The stock has a market capitalization of $26.84 million, a price-to-earnings ratio of -19.97 and a beta of 0.18. AB Corporate Bond ETF has a one year low of $33.24 and a one year high of $36.46. The company has a fifty day simple moving average of $33.77 and a 200 day simple moving average of $34.85. The company has a current ratio of 3.07, a quick ratio of 3.07 and a debt-to-equity ratio of 0.01.

AB Corporate Bond ETF Increases Dividend

The business also recently disclosed a monthly dividend, which was paid on Thursday, November 5th. Investors of record on Monday, November 2nd were paid a $0.1460 dividend. This is an increase from AB Corporate Bond ETF’s previous monthly dividend of $0.1367. This represents a $1.75 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date of this dividend was Monday, November 2nd. AB Corporate Bond ETF’s payout ratio is presently -102.38%.

About AB Corporate Bond ETF

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.